Skip to content
LSE logoGRI logo

National Health Strategy 2018-2022

·2018·Policy·AdaptationMore details
Sectors: Health

Main documents

National Health Strategy 2018-2022
  • - Promote biosimilar medicines that have the same efficacy, quality and safety as the reference biological medicine, with the objective of reaching 80% penetration of biosimilars in their reference market by 2022.Health · Target year: 2022
  • 1 prescription in the directory for every 2 prescriptionsHealth · Target year: 2020
  • Reduce antibiotics consumption by 25% by 2020Health · Target year: 2020





The summary of this document was written by researchers at the Grantham Research Institute. If you want to use this summary, please check terms of use for citation and licensing of third party data.